{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Veliparib (ABT-888)",
        "type": {
          "id": "1178250b-e88c-4be9-a92b-55757eb1f583",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "a01ef684-c2fd-4d8c-b3c0-d0efa411da0e",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "PARP inhibitor for HER2-negative metastatic or locally advanced unresectable BRCA-associated breast cancer.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Placebo",
        "type": {
          "id": "45f8d681-1d6b-463f-81c7-becbdf377e73",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "3cf5fad3-3a93-46f4-9846-9ba9d0395e84",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Matching placebo for veliparib.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Carboplatin",
        "type": {
          "id": "ca2ee435-1ce8-40d0-91d9-10cdbdf5c242",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "a0e9d91e-b1ff-4d08-ae75-9afe199bcbef",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Cytotoxic chemotherapy administered as reference therapy.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Paclitaxel",
        "type": {
          "id": "8e067955-5479-4446-a36b-d480e5b0bb8e",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "2d4a2fab-ac80-45d4-814b-bcb7762560ed",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Cytotoxic chemotherapy administered as reference therapy.",
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Corticosteroids",
        "type": {
          "id": "50b85f42-3e05-4c85-8175-6b8fce2cd985",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "be4df472-3354-4679-a72c-7e6b63cea2af",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for premedication to reduce hypersensitivity reactions.",
        "administrationIds": [
          "admin_5"
        ]
      },
      {
        "id": "int_6",
        "name": "Diphenhydramine",
        "type": {
          "id": "b59110ac-efdc-464d-8abf-169e11db4263",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "d9a4e0a5-73f2-4af4-af75-82000e275724",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "id": "int_7",
        "name": "H2 antagonists",
        "type": {
          "id": "9eba5db1-15bc-4958-afcc-6785d33206ed",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "50505df7-e384-4fae-bc0b-47fa36a43050",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "id": "int_8",
        "name": "Palonosetron",
        "type": {
          "id": "dd8d42ef-b1e7-4fbb-a2d4-9dee4868a693",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "45e639a3-ef63-4102-9d23-fd574a8a0e2f",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Recommended antiemetic for moderately emetogenic therapy."
      },
      {
        "id": "int_9",
        "name": "Dexamethasone",
        "type": {
          "id": "81f7dcc2-8775-4b81-94db-4cf816eaa78d",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "7b9a0463-a97e-4c09-82af-ec8ce07ccd01",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Recommended antiemetic for moderately emetogenic therapy."
      },
      {
        "id": "int_10",
        "name": "Aprepitant",
        "type": {
          "id": "4c144c4e-d445-4376-b084-ebf8165c0dab",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "2ef2c79d-e3a5-4682-b943-f5072741ce8c",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Optional antiemetic."
      },
      {
        "id": "int_11",
        "name": "G-CSF",
        "type": {
          "id": "80459b80-3447-42ba-8396-f5b4b32a6c4c",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "734e7a0c-4de1-4a07-a0ef-c42de33fe8bf",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Colony stimulating factor permitted for supportive care or to maintain dose intensity."
      },
      {
        "id": "int_12",
        "name": "Bisphosphonates",
        "type": {
          "id": "c59cd9d6-1607-4e5c-b4f7-71e3176f0109",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "1cbaa9ee-1f0d-4ffe-bc6b-5a272dfb2d75",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for osteoporosis or bone metastases management; prohibited for anti-cancer effect."
      },
      {
        "id": "int_13",
        "name": "Denosumab",
        "type": {
          "id": "02cd2504-214f-414a-8f70-eb68e700aceb",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "075537e2-3998-4b7d-8211-9f3198855e58",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for management of bone metastases."
      },
      {
        "id": "int_14",
        "name": "Anticancer hormonal therapy",
        "type": {
          "id": "585b2a63-eb11-44c8-ad79-bb786ce827dd",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "941c3a3d-37f0-4795-8a23-811da1c1394e",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited during the study; must be stopped 7 days before starting C1D-2."
      },
      {
        "id": "int_15",
        "name": "Chinese medicine/herbals",
        "type": {
          "id": "12f2120e-c1e5-4140-a6b9-6bd1f2f42cc4",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "8f297afc-92ee-401d-9d27-7ccdb8bc4070",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited; requires a 14-day washout period."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Veliparib",
        "administrableDoseForm": {
          "id": "e57975bb-4f49-4e22-b5dc-efd3c97cb0d5",
          "code": "C25158",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Capsule",
          "standardCode": {
            "id": "1e6569cf-d051-4df7-b26e-0ceb9e2249e2",
            "code": "C25158",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Capsule",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "59f098d4-60e1-4e30-8e31-68c7353987b9",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "AbbVie"
      },
      {
        "id": "prod_2",
        "name": "Carboplatin",
        "administrableDoseForm": {
          "id": "118f9116-52e8-4668-a44f-d2071b790179",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "87e1af38-5671-48c5-87cd-37f94b0e4364",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "f0a49de6-b559-442d-8092-38fafc1e741a",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_3",
        "name": "Paclitaxel",
        "administrableDoseForm": {
          "id": "7cc54356-e297-4a2f-9bec-5d7bfbfbd082",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "40ae464b-7a06-4229-8d06-9b695fa424fd",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "30dde43f-24fa-4f2e-8d17-f68d2477bef8",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Not specified"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Veliparib/Placebo Combination Phase",
        "instanceType": "Administration",
        "dose": "120 mg",
        "doseFrequency": "twice a day",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Days -2 through 5 of a 21-day cycle"
      },
      {
        "id": "admin_2",
        "name": "Carboplatin",
        "instanceType": "Administration",
        "dose": "AUC 6",
        "doseFrequency": "once per cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Day 1 of a 21-day cycle"
      },
      {
        "id": "admin_3",
        "name": "Paclitaxel",
        "instanceType": "Administration",
        "dose": "80 mg/m2",
        "doseFrequency": "weekly",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Days 1, 8, and 15 of a 21-day cycle"
      },
      {
        "id": "admin_4",
        "name": "Veliparib/Placebo Single-Agent Phase (Starting)",
        "instanceType": "Administration",
        "dose": "300 mg",
        "doseFrequency": "twice a day",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Days 1 through 21 of a 21-day cycle"
      },
      {
        "id": "admin_5",
        "name": "Veliparib/Placebo Single-Agent Phase (Escalated)",
        "instanceType": "Administration",
        "dose": "400 mg",
        "doseFrequency": "twice a day",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Days 1 through 21 of a 21-day cycle (if 300 mg tolerated for 2 weeks)"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Veliparib",
        "instanceType": "Substance",
        "description": "PARP inhibitor (ABT-888)"
      },
      {
        "id": "sub_2",
        "name": "Carboplatin",
        "instanceType": "Substance",
        "description": "Platinum-based chemotherapeutic agent"
      },
      {
        "id": "sub_3",
        "name": "Paclitaxel",
        "instanceType": "Substance",
        "description": "Taxane-based chemotherapeutic agent"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 15,
      "productCount": 3,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Veliparib (ABT-888)",
        "role": "Investigational Product",
        "description": "PARP inhibitor for HER2-negative metastatic or locally advanced unresectable BRCA-associated breast cancer."
      },
      {
        "name": "Placebo",
        "role": "Placebo",
        "description": "Matching placebo for veliparib."
      },
      {
        "name": "Carboplatin",
        "role": "Background Therapy",
        "description": "Cytotoxic chemotherapy administered as reference therapy."
      },
      {
        "name": "Paclitaxel",
        "role": "Background Therapy",
        "description": "Cytotoxic chemotherapy administered as reference therapy."
      },
      {
        "name": "Corticosteroids",
        "role": "Concomitant Medication",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "name": "Diphenhydramine",
        "role": "Concomitant Medication",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "name": "H2 antagonists",
        "role": "Concomitant Medication",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "name": "Palonosetron",
        "role": "Concomitant Medication",
        "description": "Recommended antiemetic for moderately emetogenic therapy."
      },
      {
        "name": "Dexamethasone",
        "role": "Concomitant Medication",
        "description": "Recommended antiemetic for moderately emetogenic therapy."
      },
      {
        "name": "Aprepitant",
        "role": "Concomitant Medication",
        "description": "Optional antiemetic."
      },
      {
        "name": "G-CSF",
        "role": "Concomitant Medication",
        "description": "Colony stimulating factor permitted for supportive care or to maintain dose intensity."
      },
      {
        "name": "Bisphosphonates",
        "role": "Concomitant Medication",
        "description": "Permitted for osteoporosis or bone metastases management; prohibited for anti-cancer effect."
      },
      {
        "name": "Denosumab",
        "role": "Concomitant Medication",
        "description": "Permitted for management of bone metastases."
      },
      {
        "name": "Anticancer hormonal therapy",
        "role": "Concomitant Medication",
        "description": "Prohibited during the study; must be stopped 7 days before starting C1D-2."
      },
      {
        "name": "Chinese medicine/herbals",
        "role": "Concomitant Medication",
        "description": "Prohibited; requires a 14-day washout period."
      }
    ],
    "products": [
      {
        "name": "Veliparib",
        "doseForm": "Capsule",
        "strength": "Not specified",
        "manufacturer": "AbbVie"
      },
      {
        "name": "Carboplatin",
        "doseForm": "Injection",
        "strength": "Not specified",
        "manufacturer": "Not specified"
      },
      {
        "name": "Paclitaxel",
        "doseForm": "Injection",
        "strength": "Not specified",
        "manufacturer": "Not specified"
      }
    ],
    "substances": [
      {
        "name": "Veliparib",
        "description": "PARP inhibitor (ABT-888)"
      },
      {
        "name": "Carboplatin",
        "description": "Platinum-based chemotherapeutic agent"
      },
      {
        "name": "Paclitaxel",
        "description": "Taxane-based chemotherapeutic agent"
      }
    ],
    "administrations": [
      {
        "name": "Veliparib/Placebo Combination Phase",
        "dose": "120 mg",
        "frequency": "twice a day",
        "route": "Oral",
        "duration": "Days -2 through 5 of a 21-day cycle"
      },
      {
        "name": "Carboplatin",
        "dose": "AUC 6",
        "frequency": "once per cycle",
        "route": "Intravenous",
        "duration": "Day 1 of a 21-day cycle"
      },
      {
        "name": "Paclitaxel",
        "dose": "80 mg/m2",
        "frequency": "weekly",
        "route": "Intravenous",
        "duration": "Days 1, 8, and 15 of a 21-day cycle"
      },
      {
        "name": "Veliparib/Placebo Single-Agent Phase (Starting)",
        "dose": "300 mg",
        "frequency": "twice a day",
        "route": "Oral",
        "duration": "Days 1 through 21 of a 21-day cycle"
      },
      {
        "name": "Veliparib/Placebo Single-Agent Phase (Escalated)",
        "dose": "400 mg",
        "frequency": "twice a day",
        "route": "Oral",
        "duration": "Days 1 through 21 of a 21-day cycle (if 300 mg tolerated for 2 weeks)"
      }
    ],
    "devices": []
  }
}